首页> 外文期刊>American pharmaceutical review >Solubility in Pharmaceutical R&D:Predictions and Reality
【24h】

Solubility in Pharmaceutical R&D:Predictions and Reality

机译:药物研发中的溶解度:预测与现实

获取原文
获取原文并翻译 | 示例
           

摘要

Lipinski's seminal paper on experimental and computational {insilico) methods to estimate the solubility and permeability of drug candidates was published just over 15-years ago [1]. Theiconic'Ruleof5'predicted that absorption was adversely impacted when the calculated LogP (cLogP) was greater than 5, when molecular weight (MW) was greater than 500, when there are greater than 5 H-bond donors or greater than 10 H-bond acceptors.The related concept of'drug-likeness'importantly focuses on both potency and physicochemical attributes, using tools such as lipophilic efficiency [2] or ligand efficiency [3].
机译:Lipinski关于实验方法和计算方法(insilico)以评估候选药物的溶解度和渗透性的开创性论文发表于15年前[1]。 Theiconic'Ruleof5'预测,当计算的LogP(cLogP)大于5,分子量(MW)大于500,氢键供体大于5或氢键大于10时,吸收会受到不利影响。 “药物相似性”的相关概念通过使用诸如亲脂效率[2]或配体效率[3]之类的工具,着重于功效和理化特性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号